These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32171317)

  • 1. A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer's disease.
    Bawa KK; Krance SH; Herrmann N; Cogo-Moreira H; Ouk M; Yu D; Wu CY; Black SE; Lanctôt KL; Swardfager W;
    J Neuroinflammation; 2020 Mar; 17(1):84. PubMed ID: 32171317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Circulating Inflammatory Markers and the Progression of Alzheimer Disease in Norwegian Memory Clinic Patients With Mild Cognitive Impairment or Dementia.
    Hazen J; Vistnes M; Barca ML; Eldholm RS; Persson K; Brækhus A; Saltvedt I; Selbæk G; Engedal K; Knapskog AB
    Alzheimer Dis Assoc Disord; 2020; 34(1):47-53. PubMed ID: 31414991
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    Wang H; Stewart T; Toledo JB; Ginghina C; Tang L; Atik A; Aro P; Shaw LM; Trojanowski JQ; Galasko DR; Edland S; Jensen PH; Shi M; Zhang J;
    J Alzheimers Dis; 2018; 61(4):1541-1553. PubMed ID: 29376878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
    Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid.
    Wu CY; Bawa KK; Ouk M; Leung N; Yu D; Lanctôt KL; Herrmann N; Pakosh M; Swardfager W
    Ageing Res Rev; 2020 Sep; 62():101130. PubMed ID: 32712109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies.
    Lai KSP; Liu CS; Rau A; Lanctôt KL; Köhler CA; Pakosh M; Carvalho AF; Herrmann N
    J Neurol Neurosurg Psychiatry; 2017 Oct; 88(10):876-882. PubMed ID: 28794151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.
    Julian A; Dugast E; Ragot S; Krolak-Salmon P; Berrut G; Dantoine T; Hommet C; Hanon O; Page G; Paccalin M
    Aging Clin Exp Res; 2015 Oct; 27(5):589-94. PubMed ID: 25700558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    Tay L; Lim WS; Chan M; Ye RJ; Chong MS
    J Nutr Health Aging; 2016 Mar; 20(3):288-99. PubMed ID: 26892578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of analgesics on executive function and memory in the Alzheimer's Disease Neuroimaging Initiative Database.
    Doan L; Choi D; Kline R;
    Scand J Pain; 2017 Oct; 17():408-417. PubMed ID: 29103867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure.
    Naudé PJ; Mommersteeg PM; Gouweleeuw L; Eisel UL; Denollet J; Westerhuis LW; Schoemaker RG
    World J Biol Psychiatry; 2015 Oct; 16(7):536-41. PubMed ID: 26212793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    Wang YL; Chen W; Cai WJ; Hu H; Xu W; Wang ZT; Cao XP; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 73(2):759-768. PubMed ID: 31839612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer's disease spectrum.
    Swanson A; Willette AA;
    Brain Behav Immun; 2016 Nov; 58():201-208. PubMed ID: 27444967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.